Vestibular migraine (VM) is one of the most debilitating chronic diseases that is currently underdiagnosed and undertreated. The treatment of VM is a dynamic and rapidly advancing area of research. New developments in this field have the potential to improve the diagnosis and provide more individualized treatments for this condition. In this review, we discussed the progress of evidence-based treatment of VM, including pharmacotherapy and nonmedical methods. A search of the literature was conducted up to September 2019. In order to control or cure VM, patients should follow three steps. First, patients should comply with diet and behavioral medication; Second, during the attack of VM, patients should take medicine to control the symptoms. These acute attack treatment of VM consists of antiemetic medications (e.g., dimenhydrinate and benzodiazepines), anti-vertigo medicine, and analgesics (e.g. triptans). Third, prophylactic medicine (e.g., propranolol, topiramate, valproic aid, lamotrigine, and flunarizine) can be used to reduce the frequency and severity of VM attack. Also, vestibular rehabilitation (VR) treatment should be considered for all VM. Meanwhile, we also propose to establish a culture of prevention which is essential for reducing the personal, social and economic burden of VM.


中文翻译：

---

前庭偏头痛的治疗：叙事回顾。


前庭偏头痛（VM）是目前诊断和治疗不足的最衰弱的慢性疾病之一。VM的治疗是一个动态且迅速发展的研究领域。该领域的新发展有可能改善诊断并针对这种情况提供更多的个性化治疗方法。在这篇综述中，我们讨论了循证医学治疗VM的进展，包括药物治疗和非医学方法。检索文献至2019年9月。为了控制或治愈VM，患者应遵循三个步骤。首先，患者应遵守饮食和行为药物；其次，在VM发作期间，患者应服药以控制症状。VM的这些急性发作治疗包括止吐药（例如，苯海拉明和苯二氮卓类药物），抗眩晕药和镇痛药（例如曲普坦）。第三，可以使用预防药（例如普萘洛尔，托吡酯，丙戊酸辅助药，拉莫三嗪和氟硝利嗪）来减少VM发作的频率和严重程度。此外，应考虑对所有VM进行前庭康复（VR）治疗。同时，我们还建议建立一种预防文化，这对于减轻VM的个人，社会和经济负担至关重要。